WEST PHARMACEUTICAL SERVICES INC
WEST PHARMACEUTICAL SERVICES INC
EXTON, PA
Loading...
Price History
Market Data
| Market Cap | 22.11B |
| P/E Ratio | 45.22 |
| P/B Ratio | 6.96 |
| EPS | 6.79 |
| Dividend Yield | 0.28% |
| D/E Ratio | 0.34 |
| Current Ratio | 3.02 |
| Currency | USD |
Key Financial Metrics
3.07B
Revenue
493.70M
Net Income
6.79
EPS (Diluted)
687.00M
Free Cash Flow
Profitability
Gross Margin
35.9%
Operating Margin
19.0%
Net Profit Margin
16.1%
EBITDA
584.90M
Returns & Efficiency
Return on Assets (ROA)
11.6%
Return on Equity (ROE)
15.5%
Dividend Yield
0.28%
EPS
6.79
Financial Health
Total Assets
4.27B
Total Debt
202.80M
Debt to Equity
0.34x
Current Ratio
3.02
Insider Trading
Last 12 months
0
Buys
0
Sells
0
Insiders
Quick Access Filings
10-K
Annual Report
Loading...
10-Q
Quarterly Report
Loading...
8-K
Recent News
Loading...
Company Data Library
Earnings Transcripts
Loading...
Press Releases
Loading...
Filing Sections
Loading...
Company Info
| Industry | Measuring, Analyzing & Controlling Instruments |
| HQ | EXTON, PA |
| Fiscal Year | 2025 |
Peers
STRYKER CORP
SYK
113.24B
P/E: --
3M CO
MMM
86.42B
P/E: --
83.53B
P/E: --
41.26B
P/E: --
RESMED INC
RSMDF
37.64B
P/E: --
DEXCOM INC
DXCM
22.94B
P/E: --
PENUMBRA INC
PEN
12.76B
P/E: 85.5
GLOBUS MEDICAL INC
GMED
12.23B
P/E: 29.9
Quick Links
Financial Statistics
Valuation
Market Cap$22.11B
P/E Ratio (TTM)45.2
Price to Book6.96
EV/Revenue-
EV/EBITDA-
Profitability
Gross Margin35.9%
Operating Margin19.0%
Net Margin16.1%
ROE15.5%
ROA11.6%
Leverage & Liquidity
Debt to Equity0.34
Current Ratio3.02
Total Debt$202.80M
Total Assets$4.27B
Stockholders' Equity$3.18B
Income Statement (FY 2025)
Revenue$3.07B
Gross Profit$1.10B
Operating Income$584.90M
Net Income$493.70M
EPS (Diluted)$6.79
Cash Flow (FY 2025)
Free Cash Flow$687.00M
Cash & Equivalents$791.30M
Revenue Growth6.3%
SEC Filings by Category
Insider Trading Activity
Neutral
0 Buys $0
0 Sales $0
0 Exercises $0
Net: $0
| Insider | Title | Date | Type | Shares | Price | Value |
|---|
Company Information
| Business Address | 530 HERMAN O. WEST DRIVE EXTON, PA 19341 |
| Phone | 6105942900 |
| Incorporated | PA, US |
| EIN | 231210010 |
| Fiscal Year End | 1231 |
| Shares Outstanding | 72.02M |
| Stockholders' Equity | $3.18B |
| Cash & Equivalents | $791.30M |
Recent Filings
View All
SCHEDULE 13G
Passive Ownership Report
Schedule 13G - passive beneficial ownership
Filed: 2026-04-30
Local
SCHEDULE 13G
Passive Ownership Report
Schedule 13G - passive beneficial ownership
Filed: 2026-04-29
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-04-29
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-04-29
Local
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-04-23
Local
10-Q
Quarterly Report
Quarterly financial report with unaudited statements
Filed: 2026-04-23
Local
8-K
Current Report
Report of material events (acquisitions, earnings, executive changes)
Filed: 2026-03-09
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-03
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-03
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-03
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-03
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-03
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-03
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-03-03
Local
4
Insider Transaction Report
Statement of changes in beneficial ownership
Filed: 2026-02-23
Local
Loading...
Loading management data...
Loading...
Loading board of directors...
Loading...
Loading institutional holders...
Loading...
Loading short interest data...
Financial Charts Annual (10-K)
Interactive financial visualizations
Show:
Revenue & Income Trends
Revenue & Profit
Profit Margins
Balance Sheet Breakdown
Assets Composition
Capital Structure
Cash Flow Analysis
Cash Flow Components
Free Cash Flow
Growth & Performance
Revenue Growth Rate (YoY %)
Key Ratio Trends
Company Profile
General Information
| Company Name | WEST PHARMACEUTICAL SERVICES INC |
| Ticker | WST |
| Exchange | -- |
| Sector | Manufacturing |
| Industry | Measuring, Analyzing & Controlling Instruments |
| Headquarters | EXTON, PA |
| Fiscal Year | 2025 |
Financial Summary
| Market Cap | 22.11B |
| Revenue | 3.07B |
| Net Income | 493.70M |
| P/E Ratio | 45.22 |
| EPS | 6.79 |
| Net Margin | 16.1% |
| ROE | 15.5% |
| Dividend Yield | 0.28% |
Insider Transactions
Loading...
My Notes & Files
Personal Notes
Attached Files
Loading...